Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Perspective Therapeutics Inc (AMEX: CATX) closed the day trading at $4.98 up 2.89% from the previous closing price of $4.84. In other words, the price has increased by $2.89 from its previous closing price. On the day, 1.02 million shares were traded. CATX stock price reached its highest trading level at $5.12 during the session, while it also had its lowest trading level at $4.86.
Ratios:
For a better understanding of CATX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.09 and its Current Ratio is at 15.09. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, BTIG Research on October 10, 2025, initiated with a Buy rating and assigned the stock a target price of $14.
On March 13, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.Scotiabank initiated its Sector Outperform rating on March 07, 2025, with a $15 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 28 ’25 when Spoor Johan M. bought 22,026 shares for $2.24 per share. The transaction valued at 49,384 led to the insider holds 59,383 shares of the business.
Spoor Johan M. bought 4,650 shares of CATX for $10,288 on Mar 28 ’25. The Chief Executive Officer now owns 4,650 shares after completing the transaction at $2.21 per share. On Mar 31 ’25, another insider, Williamson Robert F III, who serves as the Director of the company, bought 38,145 shares for $2.14 each. As a result, the insider paid 81,775 and bolstered with 108,982 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CATX now has a Market Capitalization of 369829696 and an Enterprise Value of 171423872. For the stock, the TTM Price-to-Sale (P/S) ratio is 298.25 while its Price-to-Book (P/B) ratio in mrq is 1.39. Its current Enterprise Value per Revenue stands at 138.805 whereas that against EBITDA is -2.076.
Stock Price History:
The Beta on a monthly basis for CATX is 0.99, which has changed by -0.5901234 over the last 52 weeks, in comparison to a change of 0.14201736 over the same period for the S&P500. Over the past 52 weeks, CATX has reached a high of $13.19, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is 38.20%, while the 200-Day Moving Average is calculated to be 57.76%.
Shares Statistics:
Over the past 3-months, CATX traded about 855.13K shares per day on average, while over the past 10 days, CATX traded about 1444390 shares per day. A total of 74.26M shares are outstanding, with a floating share count of 60.73M. Insiders hold about 18.23% of the company’s shares, while institutions hold 66.79% stake in the company. Shares short for CATX as of 1759190400 were 6776377 with a Short Ratio of 7.92, compared to 1756425600 on 6373501. Therefore, it implies a Short% of Shares Outstanding of 6776377 and a Short% of Float of 12.920000000000002.
Earnings Estimates
A comprehensive evaluation of Perspective Therapeutics Inc (CATX) is underway, with the input of 7.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.27 and low estimates of -$0.41.
Analysts are recommending an EPS of between -$1.01 and -$1.33 for the fiscal current year, implying an average EPS of -$1.17. EPS for the following year is -$1.34, with 7.0 analysts recommending between -$0.92 and -$1.98.
Revenue Estimates
A total of 13 analysts have provided revenue estimates for CATX’s current fiscal year. The highest revenue estimate was $1.53M, while the lowest revenue estimate was $632k, resulting in an average revenue estimate of $1.13M. In the same quarter a year ago, actual revenue was $1.45M
